Warburg Pincus has added to its healthcare portfolio with a $4.5 billion deal to buy Bausch & Lomb. While Bausch & Lomb is best known for its line of contact lenses, the company also markets a line of pharmaceuticals used to treat eye conditions. Bausch & Lomb can continue to look at other offers, but would have to pay Warburg Pincus a $40 million breakup fee if the company decides to take another bid.
- here's the report on the buyout from MarketWatch